Skip to content

Clinical trials

Phase 1 Dementia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dementia Phase: Phase 1 Clear all

75 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20044
20051
20063
20075
20083
20091
20105
20113
20122
20131
20143
20162
20173
20198
20214
20224
20233
20247
20256
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed47
Recruiting8
Unknown status7
Not yet recruiting5
Terminated4
Active, not recruiting3
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC4
National Institute of Mental Health (NIMH)3
National Institute of Neurological Disorders and Stroke (NINDS)3
Texas Christian University3
University of Kansas Medical Center3
Eli Lilly and Company2
Siena Biotech S.p.A.2
Stanford University2
Tetra Discovery Partners2
Abrexa Pharmaceuticals, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dementia75
Alzheimer Disease38
Cognitive Dysfunction19
Neurodegenerative Diseases9
Brain Diseases7
Central Nervous System Diseases7
Nervous System Diseases6
Mental Disorders5
Cognition Disorders4
Neurocognitive Disorders4

Trials

Showing 51 to 75 of 75. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.